Antimicrobial‐Associated Risk Factors for Clostridium difficile Infection

Cited by (603)

Items 101–200 of 603

1. Clostridium difficile-associated diarrhoea, a frequent complication in patients with acute myeloid leukaemia
   Enrico Schalk, Ulrich R. M. Bohr, Brigitte König, Katrin Scheinpflug, Martin Mohren · 2009 · Annals of Hematology
2. Risk Factors for Acquisition and Loss of Clostridium difficile Colonization in Hospitalized Patients
   Erik R. Dubberke, Kimberly A. Reske, Sondra M. Seiler, Tiffany Hink, Jennie H. Kwon, Carey‐Ann D. Burnham · 2015 · Antimicrobial Agents and Chemotherapy
3. Low Risk of Primary Clostridium difficile Infection With Tetracyclines: A Systematic Review and Metaanalysis
   Raseen Tariq, Janice M. Cho, Saloni Kapoor, Robert Orenstein, Siddharth Singh, Darrell S. Pardi, Sahil Khanna · 2017 · Clinical Infectious Diseases
4. Microbial resistance: The role of efflux pump superfamilies and their respective substrates
   I. Garcia, Francisca Adilfa de Oliveira Garcia, Pedro Silvino Pereira, Henrique Douglas Melo Coutinho, Abolghasem Siyadatpanah, Roghayeh Norouzi, Polrat Wilairatana, Maria de Lourdes Pereira, Veeranoot Nissapatorn, Saulo Relison Tintino et al. · 2022 · Life Sciences
5. Treatment of Enterococcus faecalis Infective Endocarditis: A Continuing Challenge
   Laura Herrera Hidalgo, Beatriz Fernández-Rubio, Rafael Luque Márquez, Luis Eduardo López-Cortés, María Victoria Gil-Navarro, Arístides de Alarcón · 2023 · Antibiotics
6. Sustained reduction in antimicrobial use and decrease in methicillin-resistant Staphylococcus aureus and Clostridium difficile infections following implementation of an electronic medical record at a tertiary-care teaching hospital
   Paul Cook, Shemra Rizzo, Michael D. Gooch, M. Jordan, Xiangming Fang, S. Hudson · 2010 · Journal of Antimicrobial Chemotherapy
7. Analysis of risk factors for malignant Mediterranean spotted fever indicates that fluoroquinolone treatment has a deleterious effect
   Élisabeth Botelho-Nevers, Clarisse Rovery, Hervé Richet, Didier Raoult · 2011 · Journal of Antimicrobial Chemotherapy
8. Unnecessary Antimicrobial Use in Patients with Current or Recent Clostridium difficile Infection
   Megan K. Shaughnessy, William H. Amundson, Michael A. Kuskowski, Douglas D. DeCarolis, James R. Johnson, Dimitri Maximilian Drekonja · 2012 · Infection Control and Hospital Epidemiology
9. Multihospital Outbreak ofClostridium difficileRibotype 027 Infection: Epidemiology and Analysis of Control Measures
   Mamoon A. Aldeyab, Michael J. Devine, Peter Flanagan, Michael Mannion, Avril Craig, Michael Scott, Stephan Harbarth, Nathalie Vernaz, Elizabeth Davies, Jon S. Brazier et al. · 2011 · Infection Control and Hospital Epidemiology
10. Time-Series Analysis of Health Care–Associated Infections in a New Hospital With All Private Rooms
    Emily Gibson McDonald, Nandini Dendukuri, Charles H. Frenette, Todd Campbell Lee · 2019 · JAMA Internal Medicine
11. Global Evolution of Pathogenic Bacteria With Extensive Use of Fluoroquinolone Agents
    M. Füzi, Jesús Rodríguez‐Baño, Ákos Tóth · 2020 · Frontiers in Microbiology
12. Effects of fluoroquinolone restriction (from 2007 to 2012) on Clostridium difficile infections: interrupted time-series analysis
    Jayanta Sarma, B. Marshall, V Cleeve, D. Tate, T. Oswald, S. Woolfrey · 2015 · Journal of Hospital Infection
13. Clostridium difficile Infection in Humans and Piglets: A ‘One Health’ Opportunity
    Michele M. Squire, Thomas Victor Riley · 2012 · Current topics in microbiology and immunology
14. Acid Suppression Therapy Does Not Predispose to Clostridium difficile Infection: The Case of the Potential Bias
    Lena Novack, Slava Kogan, Larisa Gimpelevich, Michael Howell, Abraham Borer, Ciarán P. Kelly, Daniel A. Leffler, Victor Novack · 2014 · PLoS ONE
15. Clostridium Difficile Infection in Children
    Elena Borali, Costantino De Giacomo · 2016 · Journal of Pediatric Gastroenterology and Nutrition
16. National age group trends in Clostridium difficile infection incidence and health outcomes in United States Community Hospitals
    Ashley Pechal, Kevin Lin, Stefan Allen, Kelly R. Reveles · 2016 · BMC Infectious Diseases
17. Factors associated with Clostridium difficile infection: A nested case-control study in a three year prospective cohort
    Nagham Léa Khanafer, Philippe Vanhems, Frédéric Barbut, Christine Luxemburger · 2017 · Anaerobe
18. Antimicrobial activity of natural products against Clostridium difficile in vitro
    Niloufar Roshan, Thomas Victor Riley, Katherine A. Hammer · 2017 · Journal of Applied Microbiology
19. Essential role of the glucosyltransferase activity in Clostridium difficile toxin-induced secretion of TNF-α by macrophages
    Xingmin Sun, Xiangyun He, Saul R. Tzipori, Ralf Gerhard, Hanping Feng · 2009 · Microbial Pathogenesis
20. Antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery
    Jashvant Poeran, Madhu Mazumdar, Rehana Rasul, Joanne Meyer, Henry S. Sacks, Brian S. Koll, Frances R. Wallach, Alan J. Moskowitz, Annetine C. Gelijns · 2015 · Journal of Thoracic and Cardiovascular Surgery
21. Hype or hypervirulence
    Wiep Klaas Smits · 2013 · Virulence
22. Outpatient parenteral antimicrobial therapy with ceftriaxone, a review
    Christopher James Arthur Duncan, David Adam Barr, Ronald Andrew Seaton · 2012 · International Journal of Clinical Pharmacy
23. Practice Parameters for the Management of Clostridium difficile Infection
    Scott R. Steele, James McCormick, Genevieve B. Melton, Ian M. Paquette, David E. Rivadeneira, David Alan Stewart, W. Donald Buie, Janice L. Rafferty · 2014 · Diseases of the Colon & Rectum
24. Comparative outcomes of β-lactam antibiotics in outpatient parenteral antibiotic therapy: treatment success, readmissions and antibiotic switches
    Boeun Lee, Idy Tam, Bernard Weigel, Janis L. Breeze, Jessica K. Paulus, Jason Nelson, Geneve M. Allison · 2015 · Journal of Antimicrobial Chemotherapy
25. Quasiexperimental Study of the Effects of Antibiotic Use, Gastric Acid-Suppressive Agents, and Infection Control Practices on the Incidence of Clostridium difficile -Associated Diarrhea in Hospitalized Patients
    Mamoon A. Aldeyab, Stéphan Harbarth, Nathalie Vernaz, Mary P. Kearney, Michael Scott, Chris Funston, Karen Savage, Denise Kelly, Motasem A. Aldiab, James C. McElnay · 2009 · Antimicrobial Agents and Chemotherapy
26. Experimental design considerations in microbiota/inflammation studies
    Robert J. Moore, Dragana Stanley · 2016 · Clinical & Translational Immunology
27. Frailty and the gut
    Antonio Di Sabatino, Marco Vincenzo Lenti, Lisa Cammalleri, Gino Roberto Corazza, Alberto Pilotto · 2018 · Digestive and Liver Disease
28. Intrinsic Class D β-Lactamases of Clostridium difficile
    Márta Tóth, Nichole K. Stewart, Clyde A. Smith, Sergei B. Vakulenko · 2018 · mBio
29. A Comprehensive Assessment Across the Healthcare Continuum: Risk of Hospital-Associated Clostridium difficile Infection Due to Outpatient and Inpatient Antibiotic Exposure
    Sara Yee Tartof, Gunter K. Rieg, Rong X. Wei, Hung Fu Tseng, Steven J. Jacobsen, Kalvin C. Yu · 2015 · Infection Control and Hospital Epidemiology
30. Do piperacillin/tazobactam and other antibiotics with inhibitory activity against Clostridium difficile reduce the risk for acquisition of C. difficile colonization?
    Sirisha Kundrapu, Venkata C. K. Sunkesula, Lucy A. Jury, Jennifer L. Cadnum, Michelle M. Nerandzic, Jackson Musuuza, Ajay K. Sethi, Curtis J. Donskey · 2016 · BMC Infectious Diseases
31. Electronic Health Record–Based Detection of Risk Factors for Clostridium difficile Infection Relapse
    Courtney L. Hebert, Hongyan Du, Lance R. Peterson, Ari A. Robicsek · 2013 · Infection Control and Hospital Epidemiology
32. Immunomodulatory tetracyclines shape the intestinal inflammatory response inducing mucosal healing and resolution
    José Garrido‐Mesa, Alba Rodríguez‐Nogales, Francesca Algieri, Teresa Vezza, Laura Hidalgo‐Garcia, María Garrido-Barros, M. Pilar Utrilla, Féderico García, Natalia Chueca, Maria Elena Rodríguez‐Cabezas et al. · 2018 · British Journal of Pharmacology
33. Development and Validation of a Chemostat Gut Model To Study Both Planktonic and Biofilm Modes of Growth of Clostridium difficile and Human Microbiota
    Grace S. Crowther, C. H. Chilton, Sharie L. Todhunter, Scott Nicholson, Jane Freeman, Simon D. Baines, Mark H. Wilcox · 2014 · PLoS ONE
34. Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection
    Brendan J. Kelly, Pablo Tebas · 2017 · CHEST Journal
35. Strain-Dependent Inhibition of Clostridioides difficile by Commensal Clostridia Carrying the Bile Acid-Inducible ( bai ) Operon
    Amber D. Reed, Matthew A. Nethery, Allison K. Stewart, Rodolphe Barrangou, Casey M. Theriot · 2020 · Journal of Bacteriology
36. Probiotics for the prevention of antibiotic-associated diarrhoea in older patients: a systematic review
    Xie, Chunhong, Li, Jiajing, Wang, Kejia, Li, Qinqin, Chen, Daorong · 2015 · Travel Medicine and Infectious Disease
37. Outpatient Healthcare Settings and Transmission of Clostridium difficile
    Lucy A. Jury, Brett M. Sitzlar, Sirisha Kundrapu, Jennifer L. Cadnum, Kim M. Summers, Christine P. Muganda, Abhishek Deshpande, Ajay K. Sethi, Curtis J. Donskey · 2013 · PLoS ONE
38. Clostridium difficileinfection in children: a comprehensive review
    Chaitanya Pant, Abhishek Deshpande, Muhammad Adnan Altaf, Anil Minocha, Thomas J. Sferra · 2013 · Current Medical Research and Opinion
39. Using Syndromic Surveillance to Estimate Baseline Rates for Healthcare-Associated Infections in Critical Care Units of Small Animal Referral Hospitals
    Audrey Ruple, Helen W. Aceto, Jeff B. Bender, Mary Rose Paradis, Scott P. Shaw, David C. Van Metre, Jeffrey Scott Weese, David A. Wilson, J.H. Wilson, Paul S. Morley · 2013 · Journal of Veterinary Internal Medicine
40. Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
    Jenessa A. Winston, Rajani Thanissery, Stephanie A. Montgomery, Casey M. Theriot · 2016 · Journal of Visualized Experiments
41. Multi-institution case–control and cohort study of risk factors for the development and mortality of Clostridium difficile infections in Japan
    Masahiko Takahashi, Nobuaki Mori, Seiji Bito · 2014 · BMJ Open
42. Antimicrobial Stewardship: Philosophy Versus Practice
    Elizabeth S. Dodds Ashley, Keith S. Kaye, Daryl D. DePestel, Elizabeth D. Hermsen · 2014 · Clinical Infectious Diseases
43. Antimicrobial Susceptibilities and Molecular Epidemiology of Clinical Isolates of Clostridium difficile in Taiwan
    Yi-Chun Lin, Yu‐Tsung Huang, Pei-Jane Tsai, Tai-Fen Lee, Nan–Yao Lee, Chun‐Hsing Liao, Shyr-Yi Lin, Wen‐Chien Ko, Po‐Ren Hsueh · 2011 · Antimicrobial Agents and Chemotherapy
44. Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
    for the AGIHO Working Group, Martin Schmidt‐Hieber, J. Bierwirth, Dieter Buchheidt, Oliver A. Cornely, Marcus Hentrich, Georg Maschmeyer, Enrico Schalk, Jörg Janne Vehreschild, Maria J. G. T. Vehreschild · 2017 · Annals of Hematology
45. Analysis of Clostridium difficile biofilms: imaging and antimicrobial treatment
    Garth A. James, Laurent Chesnel, Laura Boegli, Elinor deLancey Pulcini, Steve T. Fisher, Philip S. Stewart · 2017 · Journal of Antimicrobial Chemotherapy
46. Cost-Effectiveness Analysis of the Use of Point-of-Care C-Reactive Protein Testing to Reduce Antibiotic Prescribing in Primary Care
    Emily A. F. Holmes, Sharman D. Harris, Alison Hughes, Noel Craine, Dyfrig Arwyn Hughes · 2018 · Antibiotics
47. Evaluation of Repeat Clostridium difficile Enzyme Immunoassay Testing
    Diana Marcella Cardona, Kenneth H. Rand · 2008 · Journal of Clinical Microbiology
48. A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies
    Sapna Parmar, Valkal Bhatt, Jie Yang, Qiao Zhang, Michael K. Schuster · 2013 · Journal of Oncology Pharmacy Practice
49. Evolutionary epidemiology 20 years on: Challenges and prospects
    Olivier Restif · 2008 · Infection Genetics and Evolution
50. Tigecycline Exhibits Inhibitory Activity against Clostridium difficile in the Colon of Mice and Does Not Promote Growth or Toxin Production
    Robin Jump, Yuejin Li, Michael J. Pultz, George Kypriotakis, Curtis J. Donskey · 2010 · Antimicrobial Agents and Chemotherapy
51. Temporal effects of antibiotic use and Clostridium difficile infections
    Nathalie Vernaz, Kirsteen Hill, Stephanie Leggeat, Dilip Nathwani, Gabby Philips, Pascal Bonnabry, Peter G Davey · 2009 · Journal of Antimicrobial Chemotherapy
52. A proposal for a comprehensive approach to infections across the surgical pathway
    Massimo Sartelli, Léonardo Pagani, Stefania Iannazzo, Maria Luisa Moro, Pierluigi Viale, Angelo Pan, Luca Ansaloni, Federico Coccolini, Marcello Mario D’Errico, Iris Agreiter et al. · 2020 · World Journal of Emergency Surgery
53. At least it won’t hurt: the personal risks of antibiotic exposure
    Andrew James Stewardson, Benedikt David Huttner, Stephan Harbarth · 2011 · Current Opinion in Pharmacology
54. Systematic review of loperamide: No proof of antibiotics being superior to loperamide in treatment of mild/moderate travellers' diarrhoea
    Tinja Lääveri, Jesper Sterne, Lars Rombo, Anu Kantele · 2016 · Travel Medicine and Infectious Disease
55. A call to action for outpatient antibiotic stewardship
    Michael E. Klepser, Erica L. Dobson, Jason M. Pogue, Matthew J. Labreche, Alex J. Adams, Timothy P. Gauthier, R. Brigg Turner, Christy P. Su, David M. Jacobs, Katie J. Suda · 2017 · Journal of the American Pharmacists Association
56. Outcome ofClostridium difficile-associated disease in solid organ transplant recipients: a prospective and multicentre cohort study
    Óscar Len, Dolors Rodríguez-Pardo, Joan Gavaldà, José María Aguado, Marino Blanes, Núria Borrell, Germán Bou, Jordi Carratalà, José Miguel Cisneros, Jesús Fortün et al. · 2012 · Transplant International
57. Epidemiology of community-onset Clostridium difficile infection in a community in the South of England
    Gracia LT Fellmeth, Sucharita Yarlagadda, Shabnam Iyer · 2010 · Journal of Infection and Public Health
58. Identification and Characterization of a Gene Cluster Required for Proper Rod Shape, Cell Division, and Pathogenesis in Clostridium difficile
    Eric M. Ransom, Kyle Brandon Williams, David S. Weiss, Craig D. Ellermeier · 2014 · Journal of Bacteriology
59. Part 2: Treatments for Chronic Gastrointestinal Disease and Gut Dysbiosis.
    Matthew J. Bull, Nigel T Plummer · 2015 · PubMed Central
60. Clostridium difficile infection in children hospitalized due to diarrhea
    Karolina Dulęba, Małgorzata Pawłowska, Magdalena Wietlicka-Piszcz · 2013 · European Journal of Clinical Microbiology & Infectious Diseases
61. Risk Factors for the Development ofClostridium difficile-associated Colitis after Colorectal Cancer Surgery
    Chang Ho Yeom, Min Mi Cho, Seong Kyu Baek, Ok Suk Bae · 2010 · Journal of the Korean Society of Coloproctology
62. Contribution of Inhibitory Metabolites and Competition for Nutrients to Colonization Resistance against Clostridioides difficile by Commensal Clostridium
    Reed, Amber D., Theriot, Casey M. · 2021 · Microorganisms
63. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Clostridioides difficile Infection
    Vitaliy Y. Poylin, Alexander T. Hawkins, Anuradha R. Bhama, Marylise Boutros, Amy Lee Lightner, Sahil Khanna, Ian M. Paquette, Daniel L. Feingold · 2021 · Diseases of the Colon & Rectum
64. Extraintestinal Clostridium difficile Infections: A Single-Center Experience
    Arjun Gupta, Robin Patel, Larry M. Baddour, Darrell S. Pardi, Sahil Khanna · 2014 · Mayo Clinic Proceedings
65. Is it time to stop counselling patients to “finish the course of antibiotics”?
    Bradley J. Langford, Andrew Mark Morris · 2017 · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
66. Risk Factors, Incidence, and Morbidity Associated With Obstetric Clostridium difficile Infection
    Jacob Ruiter‐Ligeti, Sophie Vincent, Nicholas Czuzoj‐Shulman, Haim Arie Abenhaim · 2018 · Obstetrics and Gynecology
67. Meta-analysis of randomised trials comparing a penicillin or cephalosporin with a macrolide or lincosamide in the treatment of cellulitis or erysipelas
    Athena Ferreira, Mark J Bolland, Mark G. Thomas · 2016 · Infection
68. Infecciones producidas por Clostridium difficile
    Dolors Rodríguez-Pardo, Beatriz Mirelis, Ferrán Navarro · 2013 · Enfermedades Infecciosas y Microbiología Clínica
69. SMT19969 as a treatment for Clostridium difficile infection: an assessment of antimicrobial activity using conventional susceptibility testing and an in vitro gut model
    Simon D. Baines, Grace S. Crowther, Jane Freeman, Sharie L. Todhunter, Richard J Vickers, Mark H. Wilcox · 2014 · Journal of Antimicrobial Chemotherapy
70. The Rhoptry Pseudokinase ROP54 Modulates Toxoplasma gondii Virulence and Host GBP2 Loading
    Elliot W. Kim, Santhosh M. Nadipuram, Ashley L. Tetlow, William D. Barshop, Philip T. Liu, James Akira Wohlschlegel, Peter John Bradley · 2016 · mSphere
71. Modulation of antibiotic effects on microbial communities by resource competition
    Daniel Newton, Po-Yi Ho, Kerwyn Casey Huang · 2023 · Nature Communications
72. Risk factors, outcomes and epidemiology associated with Clostridium difficile infection in patients with haematological malignancies in a tertiary care hospital in China
    Silan Gu, Yunbo Chen, Tao� Lv, Xuewu Zhang, Zeqing Wei, Ping Shen, Lanjuan Li · 2015 · Journal of Medical Microbiology
73. Analysis of Morbidity and Mortality Outcomes in PostoperativeClostridium difficileInfection in the Veterans Health Administration
    Xinli Li, Mark A. Wilson, William A. Nylander, Tracy Schifftner Smith, Marilyn M. Lynn, William Gunnar · 2015 · JAMA Surgery
74. The Environment, Farm Animals and Foods as Sources of Clostridioides difficile Infection in Humans
    Declan Bolton, Pilar Marcos · 2023 · Foods
75. Assessing control bundles for Clostridium difficile : a review and mathematical model
    Laith Yakob, Thomas Victor Riley, David L. Paterson, John Marquess, Archie Clements · 2014 · Emerging Microbes & Infections
76. Multifaceted intervention to optimize antibiotic use for intra-abdominal infections
    Zagorka Popovski, Mathew Mercuri, Cheryl L. Main, Niv Sne, Kate Walsh, Melani Sung, Timothy J. Rice, Dominik Mertz · 2014 · Journal of Antimicrobial Chemotherapy
77. Detecting and Treating Clostridium Difficile Infections in Patients with Inflammatory Bowel Disease
    Ashwin N. Ananthakrishnan · 2012 · Gastroenterology Clinics of North America
78. Predictors ofClostridium difficileinfection severity in patients hospitalised in medical intensive care
    Nagham Léa Khanafer · 2013 · World Journal of Gastroenterology
79. Bezlotoxumab: A Novel Agent for the Prevention of Recurrent Clostridium difficile Infection
    Wesley D. Kufel, Aaron S. Devanathan, Ashley H Marx, David J. Weber, Lindsay M. Daniels · 2017 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
80. Antibiotic consumption versus the prevalence of multidrug-resistant Acinetobacter baumannii and Clostridium difficile infections at an ICU from 2014–2015
    Grzegorz Ziółkowski, Iwona Pawłowska, Lech Krawczyk, Jadwiga Wójkowska‐Mach · 2018 · Journal of Infection and Public Health
81. Characterization of Clostridium difficile Isolates from Human Fecal Samples and Retail Meat from Pennsylvania
    Jyotika Varshney, Katherine Joanne Very, Jen L. Williams, John P. Hegarty, David B. Stewart, Jeanne Lumadue, Kumar Venkitanarayanan, Bhushan M. Jayarao · 2014 · Foodborne Pathogens and Disease
82. Emerging frontiers of antibiotics use and their impacts on the human gut microbiome
    Rekha Kumari, Yasha Yadav, Richa Misra, Utpal Das, Upasana Das Adhikari, Pushkar Malakar, Gyanendra P. Dubey · 2022 · Microbiological Research
83. Diagnosis and management of gastrointestinal complications in adult cancer patients: evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
    Maria J. G. T. Vehreschild, Jörg Janne Vehreschild, Kai Hübel, Marcus Hentrich, Martin Schmidt‐Hieber, Maximilian Christopeit, Georg Maschmeyer, Enrico Schalk, Oliver A. Cornely, S. Neumann · 2013 · Annals of Oncology
84. Promiscuous, persistent and problematic: insights into current enterococcal genomics to guide therapeutic strategy
    David Hourigan, Ewelina Stefanovic, Colin Hill, R. Paul Ross · 2024 · BMC Microbiology
85. Incidence and risk of delayed surgical site infection following instrumented lumbar spine fusion
    Peter D. Lewkonia, Christian P. DiPaola, John Street · 2015 · Journal of Clinical Neuroscience
86. Clostridium difficileinfection and inflammatory bowel disease
    Saif A. Musa, Sam J. Thomson, Matthew Cowan, Tony Manibur Rahman · 2009 · Scandinavian Journal of Gastroenterology
87. A Mathematical Model to Evaluate the Routine Use of Fecal Microbiota Transplantation to Prevent Incident and Recurrent Clostridium difficile Infection
    Eric Lofgren, Rebekah W. Moehring, Deverick John Anderson, David Jay Weber, Nina H. Fefferman · 2013 · Infection Control and Hospital Epidemiology
88. Patient-Associated Risk Factors for Acquisition of Methicillin-Resistant Staphylococcus aureus in a Tertiary Care Hospital
    Jo-anne Marie Salangsang, Lee H. Harrison, Maria M. Brooks, Kathleen A. Shutt, Melissa I. Saul, Carlene A. Muto · 2010 · Infection Control and Hospital Epidemiology
89. Failure of Tigecycline to Treat Severe Clostridium Difficile Infection
    Petros Kopterides, C. Papageorgiou, Anastasia Antoniadou, Evangelos Papadomichelakis, Iraklis Tsangaris, Ioanna Dimopoulou, Apostolos Armaganidis · 2010 · Anaesthesia and Intensive Care
90. Risk of Clostridium difficile Infection in Hematology-Oncology Patients Colonized With Toxigenic C. difficile
    Cara Cannon, Jackson Musuuza, Anna Barker, Megan N. Duster, Mark Juckett, Aurora E Pop-Vicas, Nasia Safdar · 2017 · Infection Control and Hospital Epidemiology
91. Efficacy and safety of levofloxacin as a treatment for complicated urinary tract infections and pyelonephritis
    Riccardo Bientinesi, Rita Murri, Emilio Sacco · 2020 · Expert Opinion on Pharmacotherapy
92. Molecular characterization of moxifloxacin resistance from Canadian Clostridium difficile clinical isolates
    Andrew J. Walkty, David A. Boyd, Denise Gravel, Jim Hutchinson, Allison McGeer, DOROTHY L. MOORE, Andrew E. Simor, Kathryn N. Suh, Geoffrey D. Taylor, Mark A. Miller et al. · 2010 · Diagnostic Microbiology and Infectious Disease
93. Regional and seasonal variation in Clostridium difficile infections among hospitalized patients in the United States, 2001-2010
    Jacqueline R. Argamany, Samuel L Aitken, Grace C. Lee, Natalie K. Boyd, Kelly R. Reveles · 2015 · American Journal of Infection Control
94. The Stickland Reaction Precursor trans -4-Hydroxy- l -Proline Differentially Impacts the Metabolism of Clostridioides difficile and Commensal Clostridia
    Amber D. Reed, Joshua R. Fletcher, Yolanda Y. Huang, Rajani Thanissery, Alissa J. Rivera, Ruth Parsons, Allison K. Stewart, Duncan J. Kountz, Aimee Shen, Emily P. Balskus et al. · 2022 · mSphere
95. Recurrent Clostridium difficile Infection
    Claire van Nispen tot Pannerden, Annelies Verbon, Ernst Johan Kuipers · 2011 · Drugs
96. Antibiotic-Associated Diarrhea
    Christy A. Varughese, Niyati H. Vakil, Kristy M. Phillips · 2013 · Journal of Pharmacy Practice
97. Frequency of Antibiotic-Associated Diarrhea and Related Complications in Pediatric Patients Who Underwent Hypospadias Repair: a Comparative Study Using Probiotics vs Placebo
    Ciro Esposito, Agnese Roberti, Francesco Turrà, Mariapina Cerulo, Giovanni Severino, Alessandro Settimi, Maria Escolino · 2017 · Probiotics and Antimicrobial Proteins
98. Clostridium difficile carriage in adult cystic fibrosis (CF); implications for patients with CF and the potential for transmission of nosocomial infection
    D.G. Burke, M.J. Harrison, C. Fleming, Melissa M. McCarthy, C. Shortt, I. Sulaiman, Desmond M. Murphy, Joseph A. Eustace, Fergus Shanahan, Colin Hill et al. · 2016 · Journal of Cystic Fibrosis
99. Molecular epidemiology and antimicrobial susceptibility of human Clostridium difficile isolates from a single institution in Northern China
    Baoya Wang, Zhi Lv, Pingping Zhang, Jianrong Su · 2018 · Medicine
100. Clostridioides difficile in Calves in Central Italy: Prevalence, Molecular Typing, Antimicrobial Susceptibility and Association with Antibiotic Administration
     Francesca Blasi, Carmela Lovito, Elisa Albini, Luca Bano, Gastone Dalmonte, Ilenia Drigo, Carmen Maresca, Francesca Romana Massacci, Serenella Orsini, Sara Primavilla et al. · 2021 · Animals